Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aloxistatin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aloxistatin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(aloxistatin)		Trials
(aloxistatin)		Recent Studies (post-2010) (aloxistatin)
9,156187552153138

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)aloxistatin (IC50)
calpain II, partialSus scrofa (pig)1.7742
Calpain-1 catalytic subunitHomo sapiens (human)4
Procathepsin LHomo sapiens (human)2.41
Cathepsin GHomo sapiens (human)1.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, J; Hiraishi, S; Ishii, H; Kazama, M; Kuboki, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aloxistatin

ArticleYear
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.
    Thrombosis research, 1990, Mar-15, Volume: 57, Issue:6

    Topics: Adult; Blood Platelets; Calpain; Cysteine Proteinase Inhibitors; Enzyme Activation; Humans; Inositol Phosphates; Leucine; Phosphatidylinositols; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Serotonin; Thrombin; Type C Phospholipases

1990